Study Stopped
Satisfactory results, in terms of both clinical and statistical, were achieved.
Gilles de la Tourette Syndrome (TS) and Seasonality
2 other identifiers
observational
39
1 country
1
Brief Summary
This retrospective and prospective observational study intends to evaluate the correlation between seasons and the variation of the syndromic structure of the Tourette.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 6, 2018
CompletedFirst Submitted
Initial submission to the registry
December 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2019
CompletedFirst Posted
Study publicly available on registry
September 3, 2019
CompletedMay 9, 2023
August 1, 2019
1.2 years
December 29, 2018
May 8, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline Y-GTSS score at 6 months.
The primary objective is to investigate the correlation between seasons and different phenotypic variation through the administration of a specific questionnaire (Y-GTSS) and questions about the subjective perception of the ticcogenic variation.
4, 8, 12 months.
Secondary Outcomes (1)
Change from baseline Y-BOCS score at 6 months.
4, 8, 12 months.
Interventions
According to clinical practice, the following questionnaires are administered: * Y-GTSS * Y-BOCS or cY-BOCS
Eligibility Criteria
Being a pilot study it was not possible to develop a sample study, but the sample number is designed based on the tourette center turnout
You may qualify if:
- Patients attending the Tourette Center since January 2012.
- Males and females.
- Age between 6 and 50 (completed).
- Diagnosis of Tourette syndrome ascertained
- Presence of a value equal to or greater than 15/40 of the Y-BOCS.
You may not qualify if:
- Presence of allergic pathology.
- Presence of significant psychiatric symptoms, with the exception of those belonging to the Tourette Syndrome itself (eg ADHD, OCD)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Galeazzi Hospital
Milan, Lombardy, 20161, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mauro Porta
IRCCS Orthopedic Institute Galeazzi
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2018
First Posted
September 3, 2019
Study Start
April 6, 2018
Primary Completion
May 31, 2019
Study Completion
May 31, 2019
Last Updated
May 9, 2023
Record last verified: 2019-08